Literature DB >> 7668262

Evidence that the ancestral haplotype in Australian hemochromatosis patients may be associated with a common mutation in the gene.

D H Crawford1, L W Powell, B A Leggett, J S Francis, L M Fletcher, S I Webb, J W Halliday, E C Jazwinska.   

Abstract

Hemochromatosis (HC) is a common inherited disorder of iron metabolism for which neither the gene nor biochemical defect have yet been identified. The aim of this study was to look for clinical evidence that the predominant ancestral haplotype in Australian patients is associated with a common mutation in the gene. We compared indices of iron metabolism and storage in three groups of HC patients categorized according to the presence of the ancestral haplotype (i.e., patients with two copies, one copy, and no copies of the ancestral haplotype). We also examined iron indices in two groups of HC heterozygotes (those with the ancestral haplotype and those without) and in age-matched controls. These analyses indicate that (i) HC patients with two copies of the ancestral haplotype show significantly more severe expression of the disorder than those with one copy or those without, (ii) HC heterozygotes have partial clinical expression, which may be influenced by the presence of the ancestral haplotype in females but not in males, and (iii) the high population frequency of the HC gene may be the result of the selective advantage conferred by protecting heterozygotes against iron deficiency.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7668262      PMCID: PMC1801553     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  18 in total

1.  Association of HLA-A3 and HLA-B14 antigens with idiopathic haemochromatosis.

Authors:  M Simon; M Bourel; R Fauchet; B Genetet
Journal:  Gut       Date:  1976-05       Impact factor: 23.059

2.  Expression of hemochromatosis in homozygous subjects. Implications for early diagnosis and prevention.

Authors:  L W Powell; K M Summers; P G Board; E Axelsen; S Webb; J W Halliday
Journal:  Gastroenterology       Date:  1990-06       Impact factor: 22.682

3.  Age-related changes in laboratory values used in the diagnosis of anemia and iron deficiency.

Authors:  R Yip; C Johnson; P R Dallman
Journal:  Am J Clin Nutr       Date:  1984-03       Impact factor: 7.045

4.  Evidence for heterogeneity in hereditary hemochromatosis. Evaluation of 174 persons in nine families.

Authors:  W A Muir; G D McLaren; W Braun; A Askari
Journal:  Am J Med       Date:  1984-05       Impact factor: 4.965

5.  Idiopathic haemochromatosis in the Australian population: HLA linkage and recessivity.

Authors:  T J Doran; H V Bashir; J Trejaut; M L Bassett; J W Halliday; L W Powell
Journal:  Hum Immunol       Date:  1981-05       Impact factor: 2.850

6.  Hereditary hemochromatosis. Phenotypic expression of the disease.

Authors:  G E Cartwright; C Q Edwards; K Kravitz; M Skolnick; D B Amos; A Johnson; L Buskjaer
Journal:  N Engl J Med       Date:  1979-07-26       Impact factor: 91.245

7.  Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis.

Authors:  M L Bassett; J W Halliday; L W Powell
Journal:  Hepatology       Date:  1986 Jan-Feb       Impact factor: 17.425

8.  Factors affecting the concentrations of ferritin in serum in a healthy Australian population.

Authors:  B A Leggett; N N Brown; S J Bryant; L Duplock; L W Powell; J W Halliday
Journal:  Clin Chem       Date:  1990-07       Impact factor: 8.327

9.  Identification of homozygous hemochromatosis subjects by measurement of hepatic iron index.

Authors:  K M Summers; J W Halliday; L W Powell
Journal:  Hepatology       Date:  1990-07       Impact factor: 17.425

10.  The Wilson disease gene: spectrum of mutations and their consequences.

Authors:  G R Thomas; J R Forbes; E A Roberts; J M Walshe; D W Cox
Journal:  Nat Genet       Date:  1995-02       Impact factor: 38.330

View more
  14 in total

1.  Of metals, mice, and men: what animal models can teach us about body iron loading.

Authors:  G J Anderson; L W Powell
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

2.  The origin and spread of the HFE-C282Y haemochromatosis mutation.

Authors:  S Distante; K J H Robson; J Graham-Campbell; A Arnaiz-Villena; P Brissot; Mark Worwood
Journal:  Hum Genet       Date:  2004-09       Impact factor: 4.132

Review 3.  When less is more: gene loss as an engine of evolutionary change.

Authors:  M V Olson
Journal:  Am J Hum Genet       Date:  1999-01       Impact factor: 11.025

4.  Haplotype analysis of hemochromatosis: evaluation of different linkage-disequilibrium approaches and evolution of disease chromosomes.

Authors:  R S Ajioka; L B Jorde; J R Gruen; P Yu; D Dimitrova; J Barrow; E Radisky; C Q Edwards; L M Griffen; J P Kushner
Journal:  Am J Hum Genet       Date:  1997-06       Impact factor: 11.025

5.  Iron loading and morbidity among relatives of HFE C282Y homozygotes identified either by population genetic testing or presenting as patients.

Authors:  C A McCune; D Ravine; K Carter; H A Jackson; D Hutton; J Hedderich; M Krawczak; M Worwood
Journal:  Gut       Date:  2005-09-20       Impact factor: 23.059

Review 6.  Factors influencing disease phenotype and penetrance in HFE haemochromatosis.

Authors:  J Rochette; G Le Gac; K Lassoued; C Férec; K J H Robson
Journal:  Hum Genet       Date:  2010-07-06       Impact factor: 4.132

7.  The significance of haemochromatosis gene mutations in the general population: implications for screening.

Authors:  M J Burt; P M George; J D Upton; J A Collett; C M Frampton; T M Chapman; T A Walmsley; B A Chapman
Journal:  Gut       Date:  1998-12       Impact factor: 23.059

Review 8.  Recent advances in understanding haemochromatosis: a transition state.

Authors:  K J H Robson; A T Merryweather-Clarke; E Cadet; V Viprakasit; M G Zaahl; J J Pointon; D J Weatherall; J Rochette
Journal:  J Med Genet       Date:  2004-10       Impact factor: 6.318

9.  Duodenal expression of iron transport molecules in untreated haemochromatosis subjects.

Authors:  K A Stuart; G J Anderson; D M Frazer; L W Powell; M McCullen; L M Fletcher; D H G Crawford
Journal:  Gut       Date:  2003-07       Impact factor: 23.059

10.  Dupuytren's Contracture in Alabama HFE Hemochromatosis Probands.

Authors:  James C Barton; J Clayborn Barton
Journal:  Clin Med Insights Arthritis Musculoskelet Disord       Date:  2012-08-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.